8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cancer & Tumors

Investigating the expression changes of several key genes in prostate cancer cells under exposure to the ELF pulsed electromagnetic fields

Bioeffects Seen

Authors not listed · 2025

Share:

Controlled high-intensity pulsed EMF killed prostate cancer cells by activating tumor suppressor genes.

Plain English Summary

Summary written for general audiences

Researchers exposed prostate cancer cells to extremely low-frequency pulsed electromagnetic fields at 22.6 and 35 mT intensities. The treatment killed cancer cells and activated genes that suppress tumors while reducing genes that promote cancer growth. This suggests EMF therapy could potentially help treat prostate cancer with fewer side effects than traditional treatments.

Why This Matters

This research represents a fascinating inversion of the typical EMF health narrative. While we usually discuss EMF as a potential health risk, this study demonstrates therapeutic potential for specific, controlled electromagnetic exposures in cancer treatment. The science shows that precise ELF pulsed fields can selectively trigger cancer cell death while activating the body's natural tumor suppression mechanisms. What makes this particularly significant is the targeted genetic response - the fields increased PTEN and BAX expression (genes that fight cancer) while reducing MIR-21 and BCL-2 (genes that help cancer survive). However, it's crucial to understand that these are extremely high-intensity, precisely controlled laboratory exposures - vastly different from the low-level, chronic EMF we encounter from power lines and appliances in daily life. The reality is that therapeutic EMF applications require specific parameters that bear no resemblance to environmental EMF pollution.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2025). Investigating the expression changes of several key genes in prostate cancer cells under exposure to the ELF pulsed electromagnetic fields.
Show BibTeX
@article{investigating_the_expression_changes_of_several_key_genes_in_prostate_cancer_cells_under_exposure_to_the_elf_pulsed_electromagnetic_fields_ce3964,
  author = {Unknown},
  title = {Investigating the expression changes of several key genes in prostate cancer cells under exposure to the ELF pulsed electromagnetic fields},
  year = {2025},
  doi = {10.1038/s41598-025-20910-0},
  
}
DOI: 10.1038/s41598-025-20910-0PubMed: 41145584

Quick Questions About This Study

Yes, this study found that 35 mT ELF pulsed fields significantly increased cancer cell death rates in DU-145 prostate cancer cells. Higher field intensities and longer exposure times produced greater cancer cell mortality through targeted genetic changes.
The research demonstrated that both 22.6 mT and 35 mT pulsed electromagnetic fields significantly increased PTEN gene expression in prostate cancer cells. PTEN is a crucial tumor suppressor that helps prevent cancer cell growth and survival.
ELF pulsed electromagnetic field exposure significantly reduced MIR-21 oncogene expression in prostate cancer cells. MIR-21 normally promotes cancer growth and survival, so reducing its expression helps trigger cancer cell death through apoptosis.
The pulsed EMF treatment increased BAX gene expression, which promotes cancer cell death, while reducing BCL-2 expression, which normally blocks cell death. This genetic shift favors apoptosis in cancer cells while leaving healthy cells unaffected.
Both field strengths showed therapeutic effects, but 35 mT produced greater cancer cell mortality than 22.6 mT. The study found a dose-response relationship where higher intensities and longer exposures increased the anti-cancer effects significantly.